Thermo Fisher Scientific Inc.TMONYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+12.5%
5Y CAGR-9.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+12.5%/yr
Quarterly compound
5Y CAGR
-9.9%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 18.48% |
| Q3 2025 | 1.36% |
| Q2 2025 | 4.18% |
| Q1 2025 | -18.87% |
| Q4 2024 | 18.37% |
| Q3 2024 | 8.99% |
| Q2 2024 | 2.21% |
| Q1 2024 | -13.61% |
| Q4 2023 | 0.86% |
| Q3 2023 | 10.84% |
| Q3 2023 | 4.52% |
| Q2 2023 | -14.16% |
| Q4 2022 | 12.98% |
| Q4 2022 | -9.48% |
| Q3 2022 | -31.70% |
| Q2 2022 | 6.08% |
| Q4 2021 | 14.10% |
| Q4 2021 | 4.31% |
| Q3 2021 | -26.80% |
| Q2 2021 | -1.95% |
| Q4 2020 | 31.16% |
| Q3 2020 | 65.24% |
| Q2 2020 | 52.48% |
| Q1 2020 | -25.22% |
| Q4 2019 | 28.44% |
| Q3 2019 | -6.44% |
| Q2 2019 | 11.63% |
| Q1 2019 | -20.30% |
| Q4 2018 | 34.73% |
| Q3 2018 | -8.23% |
| Q2 2018 | 13.74% |
| Q1 2018 | -16.35% |
| Q4 2017 | 31.21% |
| Q3 2017 | -1.16% |
| Q3 2017 | 9.62% |
| Q2 2017 | -16.22% |
| Q4 2016 | 21.96% |
| Q4 2016 | 8.94% |
| Q3 2016 | 23.11% |
| Q2 2016 | -24.96% |